Study guide

23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest

EDAIC Part I European Diploma in Anaesthesiology and Intensive Care

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The EDAIC Part I Examination

1.1 EDAIC Part I Exam Format, Scoring and Multiple True/False Strategy

2 Chapter 2: Anatomy for Anaesthesia and Intensive Care

2.1 Functional Anatomy of the Upper Airway, Larynx, and Tracheobronchial Tree 2.2 Neuraxial Anatomy: Spine, Spinal Cord, Meninges, and Spaces 2.3 Vascular Anatomy for Central and Peripheral Cannulation 2.4 Peripheral Nerve Plexuses and Autonomic Nervous System Pathways 2.5 Thoracic Anatomy: Chest Wall, Intercostal Spaces, Pleura, Mediastinum and Heart

3 Chapter 3: Respiratory and Cardiovascular Physiology

3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing 3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology 3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function 3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics

4 Chapter 4: Neurophysiology, Renal, Hepatic and Acid-Base Physiology

4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics 4.2 Renal Physiology, Glomerular Filtration, and Tubular Transport 4.3 Hepatic Blood Flow, Metabolism, and Clearance 4.4 Acid-Base Regulation, Buffering Systems, and Stewart Approach

5 Chapter 5: Endocrine and Haematological Physiology

5.1 Endocrine Physiology and the Neuroendocrine Stress Response 5.2 Haemostasis Physiology, Coagulation Testing and Inherited Bleeding Disorders

6 Chapter 6: Special Patient Physiology: Maternal, Paediatric and Geriatric

6.1 Maternal Physiological Adaptations to Pregnancy and Uteroplacental Flow 6.2 Neonatal and Paediatric Physiological Differences 6.3 Physiological Changes of Ageing and Thermoregulation

7 Chapter 7: General Pharmacological Principles and Inhalational Anaesthetics

7.1 Pharmacokinetic Principles, Compartmental Models, and Clearance 7.2 Pharmacodynamic Mechanisms, Receptor Theory, and Drug Interactions 7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics 7.4 Minimum Alveolar Concentration (MAC), Organ Effects, and Toxicity

8 Chapter 8: Intravenous Agents, Neuromuscular Blockade and Analgesics

8.1 Intravenous Induction Agents: Propofol, Etomidate, Ketamine, and Barbiturates 8.2 Neuromuscular Blocking Agents: Depolarizing and Non-Depolarizing Drugs 8.3 Neuromuscular Monitoring and Reversal: Anticholinesterases and Sugammadex 8.4 Opioid Pharmacology, Receptors, and Non-Opioid Analgesic Agents

9 Chapter 9: Cardiovascular Drugs, Autonomic Pharmacology and Local Anaesthetics

9.1 Inotropes, Vasopressors, and Inodilators in Perioperative Care 9.2 Antiarrhythmic, Antihypertensive, and Beta-Adrenergic Antagonist Drugs 9.3 Local Anaesthetic Pharmacology, Toxicity (LAST), and Lipid Emulsion Therapy

10 Chapter 10: Haematological and Internal Medicine Pharmacology

10.1 Anticoagulant, Antiplatelet and Haemostatic Drugs and Their Reversal 10.2 Internal Medicine Drugs: Endocrine, Respiratory, Psychiatric and Antiepileptic Agents and Their Anaesthetic Interactions

11 Chapter 11: Physics, Clinical Measurement and Medical Equipment

11.1 Physical Gas Laws, Fluid Dynamics, and Resistance Principles 11.2 Anaesthetic Machines, Gas Supply Pipelines, Cylinders, and Safety Mechanisms 11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems 11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring

12 Chapter 12: Electrical Safety, Temperature, Humidity and Gas Analysis

12.1 Electricity, Electrical Safety, Diathermy, Defibrillation, Implanted Devices and Fire 12.2 Temperature Measurement, Humidity, Gas Analysis and SI Units

13 Chapter 13: Biostatistics, Clinical Trials and Evidence Appraisal

13.1 Descriptive Statistics, Distributions, and Parametric vs Non-Parametric Tests 13.2 Hypothesis Testing, Power, Type I/II Errors, and Confidence Intervals 13.3 Clinical Study Designs, Bias, and Diagnostic Test Performance (Sensitivity, Specificity, ROC)

14 Chapter 14: General Anaesthesia, Preoperative Evaluation and Airway Management

14.1 Preoperative Risk Assessment, Cardiovascular Risk Indices, and Fasting Guidelines 14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation 14.3 Intraoperative Fluid Therapy, Goal-Directed Hemodynamics, and Blood Conservation 14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting

15 Chapter 15: Coexisting Disease and Preoperative Investigations

15.1 Interpreting Investigations: ECG, Chest Radiograph, Lung Function and Blood Tests 15.2 Coexisting Disease I: Asthma, COPD, Obstructive Sleep Apnoea, Obesity, Liver and Renal Disease 15.3 Endocrine Disease and Emergencies: Diabetes, DKA and HHS, Thyroid, Adrenal, Phaeochromocytoma and Carcinoid 15.4 Coexisting Disease II: Neuromuscular and Neurological Disease

16 Chapter 16: Subspecialty Anaesthesia: Cardiothoracic, Vascular and Neuroanaesthesia

16.1 Anaesthesia for Cardiac Surgery and Cardiopulmonary Bypass Management 16.2 Thoracic Anaesthesia, One-Lung Ventilation, and Major Vascular Surgery 16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury

17 Chapter 17: Obstetric, Paediatric and Ambulatory Anaesthesia

17.1 Obstetric Analgesia and Anaesthesia: Labour, Caesarean Delivery, and High-Risk Conditions 17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies 17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia

18 Chapter 18: Anaesthetic Complications and Specialty Settings

18.1 Anaesthetic Complications: Accidental Awareness, Aspiration, Positioning Injuries, Visual Loss and Dental Damage 18.2 Anaesthesia for ENT and Laser Airway Surgery, Ophthalmic Surgery, and Laparoscopic and Robotic Surgery

19 Chapter 19: Regional Anaesthesia and Acute/Chronic Pain Management

19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia 19.2 Upper and Lower Limb Peripheral Nerve and Fascial Plane Blocks 19.3 Multimodal Acute Postoperative Pain Management and ERAS Pathways 19.4 Chronic and Neuropathic Pain Syndromes and Interventional Management 19.5 Palliative Symptom Control, Psychological Aspects of Pain and Multidisciplinary Pain Management

20 Chapter 20: Intensive Care Medicine: Ventilation, Shock and Organ Support

20.1 Acute Respiratory Distress Syndrome (ARDS) and Mechanical Ventilation Strategies 20.2 Sepsis-3 Definitions, Septic Shock, and Hemodynamic Resuscitation 20.3 Acute Kidney Injury, Indications for Dialysis, and Continuous Renal Replacement Therapy 20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination

21 Chapter 21: Intensive Care Medicine: Admission, Nutrition, Infection and Electrolytes

21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis 21.2 Antimicrobial Therapy, Stewardship and ICU-Acquired Infections 21.3 Electrolyte Disorders: Sodium, Potassium, Calcium, Magnesium and Phosphate

22 Chapter 22: Intensive Care and Emergency Medicine: Neurocritical Care, Poisoning and Cardiorespiratory Emergencies

22.1 Neurocritical Care: Subarachnoid Haemorrhage, Stroke, Status Epilepticus and Acute Neuromuscular Failure 22.2 Acute Poisoning: Toxidromes, Decontamination and Specific Antidotes 22.3 Acute Cardiorespiratory Emergencies: Pulmonary Embolism, Acute Severe Asthma and COPD, Non-Invasive Support and Acute Heart Failure

23 Chapter 23: Resuscitation, Perioperative Emergencies and Professional Ethics

23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest 23.2 Perioperative Crises: Malignant Hyperthermia and Severe Anaphylaxis 23.3 Major Trauma, Hemorrhagic Shock, and Massive Transfusion Protocols 23.4 Professional Ethics, Informed Consent, Patient Safety, and Helsinki Declaration

24 Chapter 24: Newborn, Paediatric and Obstetric Emergencies

24.1 Newborn Life Support and Paediatric Life Support 24.2 Obstetric Emergencies: Maternal Collapse, Amniotic Fluid Embolism, Uterine Inversion and Resuscitative Hysterotomy

25 Chapter 25: Burns, Environmental Emergencies and Patient Transport

25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness 25.2 Prehospital Care and Intra- and Inter-Hospital Transport of the Critically Ill

23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest

Key Takeaways Explain This Topic AI

High-quality chest compressions require a rate of 100-120 compressions per minute, an adult depth of 5-6 cm, complete chest wall recoil, and minimizing compression interruptions to under 10 seconds.

For shockable rhythms (VF/pVT), deliver a single biphasic shock of 150-200 J followed by immediate CPR for 2 minutes before rhythm reassessment; adrenaline (1 mg) and amiodarone (300 mg) are administered after the third shock, with amiodarone repeated at 150 mg after the fifth shock.

Perioperative cardiac arrest is predominantly witnessed, monitored, and precipitated by unique physiological or surgical triggers (vagal reflexes, high spinal block, pneumoperitoneum, air embolism, LAST, cement reaction), necessitating immediate 100% oxygen, cessation of volatile agents, and surgical communication.

Post-ROSC care prioritizes temperature control (keeping temperature at or below 37.5°C for at least 72 hours in patients who remain comatose, ERC-ESICM 2025), avoiding hypotension (MAP of at least 65 mmHg), normoxia (SpO2 94-98%), normocapnia (PaCO2 35-45 mmHg), and multimodal neuroprognostication delayed until >= 72 hours post-ROSC.

Last updated: October 2026

23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest

Resuscitation in the perioperative environment occupies a unique niche within critical care medicine. While out-of-hospital cardiac arrest (OHCA) is typically unwitnessed and dominated by ischemic heart disease, intraoperative cardiac arrest (IOCA) occurs in a heavily monitored patient with established vascular and airway access. Consequently, immediate identification of reversible triggers, adaptation of standard European Resuscitation Council (ERC) algorithms, and seamless team communication between anaesthetists and surgeons represent essential competencies for specialist practice.

1. High-Quality CPR Mechanics and Physiological Determinants of ROSC

The fundamental physiological goal of external chest compressions is the generation of forward cardiac output to maintain coronary perfusion pressure ( C P P CPP CPP ) and cerebral perfusion pressure. During cardiac arrest, myocardial blood flow occurs almost exclusively during the decompression (relaxation) phase of chest compressions. C P P = D B P − R A P CPP = DBP - RAP CPP = D BP − R A P

Where D B P DBP D BP is aortic diastolic blood pressure and R A P RAP R A P is right atrial pressure during the relaxation phase. Robust human and animal data demonstrate that a coronary perfusion pressure of at least 15 mmHg 15\text{ mmHg} 15 mmHg is mandatory to achieve return of spontaneous circulation (ROSC). Compression parameters directly dictate whether this hemodynamic threshold is reached:

Compression Rate: 100 – 120 compressions per minute 100\text{--}120\text{ compressions per minute} 100 – 120 compressions per minute . Rates exceeding 120 min − 1 120\text{ min}^{-1} 120 min − 1 compromise diastolic filling time, while rates below 100 min − 1 100\text{ min}^{-1} 100 min − 1 generate insufficient mean pressure.

Compression Depth: 5 – 6 cm 5\text{--}6\text{ cm} 5 – 6 cm in the average adult (approximately one-third of the anterior-posterior thoracic diameter). Depths exceeding 6 cm 6\text{ cm} 6 cm exponentially increase thoracic trauma (rib fractures, cardiac contusion, liver laceration) without enhancing organ perfusion.

Complete Recoil: Allowing the chest wall to re-expand fully between compressions without leaning prevents sustained elevation of intrathoracic pressure, which impairs venous return and drops C P P CPP CPP .

Minimizing Interruptions: Hands-off time must be strictly limited to < 10 seconds <10\text{ seconds} < 10 seconds for rhythm analysis or defibrillation. Perfusion pressure drops precipitously to baseline within seconds of compression cessation and requires multiple consecutive compressions to rebuild.

End-Tidal CO 2 \text{CO}_2 CO 2 ​ ( E T CO 2 ET\text{CO}_2 ET CO 2 ​ ) Monitoring: Continuous capnography serves as a real-time monitor of pulmonary blood flow and compression quality. An E T CO 2 < 10 mmHg ET\text{CO}_2 < 10\text{ mmHg} ET CO 2 ​ < 10 mmHg signifies inadequate compression mechanics or severe hypovolemia, whereas values > 20 mmHg >20\text{ mmHg} > 20 mmHg indicate effective chest compressions. A sudden, sustained spike in E T CO 2 ET\text{CO}_2 ET CO 2 ​ (often > 35 – 40 mmHg >35\text{--}40\text{ mmHg} > 35 – 40 mmHg ) is the most sensitive early clinical indicator of ROSC, preceding palpable arterial pulsations.

  • 2. ERC Adult ALS Algorithms: Shockable and Non-Shockable Pathways [ Cardiac Arrest Recognized ]
  • |
  • +----------------+----------------+
  • | |
  • [ Shockable Rhythm ] [ Non-Shockable Rhythm ]
  • (VF / pVT) (PEA / Asystole)
  • | |
  • 1 Defibrillation Shock CPR 2 min
  • (150-200 J Biphasic) Adrenaline 1 mg IV/IO
  • | (as soon as accessible)
  • CPR 2 min |
  • | Search for 4 H's / 4 T's
  • Rhythm Check (Shock 2) |
  • | Rhythm Check q2min
  • CPR 2 min Adrenaline q3-5min
  • |
  • Rhythm Check (Shock 3)
  • |
  • +-------------+-------------+
  • | |
  • Adrenaline 1 mg IV Amiodarone 300 mg IV
  • (repeat q3-5min) (repeat 150 mg after Shock 5)
  • Shockable Rhythms: Ventricular Fibrillation (VF) and Pulseless Ventricular Tachycardia (pVT)

Immediate Defibrillation: Deliver a single unsynchronized biphasic shock of 150 – 200 J 150\text{--}200\text{ J} 150 – 200 J (or manufacturer-recommended level; 360 J 360\text{ J} 360 J if an older monophasic defibrillator is utilized).

Immediate Resumption of CPR: Instantly resume high-quality chest compressions for 2 minutes without pausing to inspect the monitor or palpate pulses. Post-shock myocardial stunning often causes a pulseless rhythm for the first 30 – 60 seconds 30\text{--}60\text{ seconds} 30 – 60 seconds even if electrical defibrillation is successful.

Pharmacotherapy Schedule:

Adrenaline (Epinephrine): Administer 1 mg 1\text{ mg} 1 mg IV/IO after the third shock (during the subsequent 2 minutes of CPR), and repeat every alternate cycle (every 3 – 5 minutes 3\text{--}5\text{ minutes} 3 – 5 minutes ). Adrenaline provides alpha-1-mediated vasoconstriction, elevating systemic vascular resistance and aortic diastolic pressure to enhance C P P CPP CPP .

Amiodarone: Administer an initial bolus of 300 mg 300\text{ mg} 300 mg IV/IO diluted in 20 mL 20\text{ mL} 20 mL of 5% glucose after the third shock . If VF/pVT persists after the fifth shock , administer a supplementary bolus of 150 mg 150\text{ mg} 150 mg IV/IO.

Lidocaine: Approved as the first-line alternative if amiodarone is unavailable: 100 mg 100\text{ mg} 100 mg IV/IO after the third shock, followed by a supplementary 50 mg 50\text{ mg} 50 mg after the fifth shock.

Refractory VF (ERC 2025): After three unsuccessful shocks, consider changing the defibrillation vector (for example to anteroposterior pad placement); double sequential defibrillation is not recommended outside research.

Non-Shockable Rhythms: Pulseless Electrical Activity (PEA) and Asystole

Immediate CPR: Begin continuous compressions and ventilations (30:2 ratio if un-intubated; continuous asynchronous compressions with ventilations at 10 breaths/min 10\text{ breaths/min} 10 breaths/min if an advanced airway is in situ). Avoid hyperventilation, which increases intrathoracic pressure and reduces venous return.

Immediate Adrenaline: Administer Adrenaline 1 mg 1\text{ mg} 1 mg IV/IO as soon as vascular access is established , repeating every alternate 2-minute cycle ( 3 – 5 minutes 3\text{--}5\text{ minutes} 3 – 5 minutes ). Early adrenaline in non-shockable rhythms is correlated with improved neurological survival.

Search for Reversible Causes: PEA and asystole are almost always secondary to profound physiological derangements. Resuscitation relies on identifying and correcting the underlying pathology before irreversible hypoxic arrest ensues.

3. Systematic Identification of the 4 H's and 4 T's

Classification Etiology Perioperative Manifestations and Clues Immediate Directed Intervention

Hypoxia Airway / Lung Disconnection, bronchospasm, endobronchial intubation, aspiration, laryngospasm Hand ventilate with 100% O 2 \text{O}_2 O 2 ​ , verify tube position with fiberoptic bronchoscope.

Hypovolemia Hemorrhage / Fluid Concealed surgical bleeding, retroperitoneal hemorrhage, unreplaced third-space losses Rapid transfusion via level-1 infuser, surgical packing, cross-clamping aorta.

Hyper/Hypokalemia & Metabolic Electrolyte / Acid-base Massive transfusion (hyperkalemia), renal failure, diabetic ketoacidosis, severe lactic acidosis 10% Calcium chloride 10 mL 10\text{ mL} 10 mL , insulin-dextrose, sodium bicarbonate 50 – 100 mmol 50\text{--}100\text{ mmol} 50 – 100 mmol .

Hypo/Hyperthermia Thermal Cold operating rooms, unwarmed irrigation fluids; or malignant hyperthermia Active warming with convective blankets and fluid warmers; or dantrolene and active cooling.

Tension Pneumothorax Pulmonary Pressure Central venous line placement, laparoscopy barotrauma, chest trauma, sudden peak pressure surge Immediate needle decompression (2nd ICS mid-clavicular or 5th ICS anterior axillary) followed by thoracostomy.

Tamponade (Cardiac) Pericardial Post-sternotomy bleeding, penetrating thoracic trauma, central line cardiac perforation Emergency re-sternotomy, surgical drainage, ultrasound-guided pericardiocentesis.

Toxins Pharmacological Local anaesthetic systemic toxicity (LAST), volatile anaesthetic overdose, inadvertent IV boluses 20% Lipid emulsion therapy (Intralipid), turn off all anaesthetic vaporizers and infusions.

Thrombosis Thromboembolic Massive pulmonary embolism (PE), acute coronary syndrome, cement embolization Surgical/catheter embolectomy, systemic thrombolysis (e.g. alteplase 50 mg 50\text{ mg} 50 mg ), CPR for 60-90 min.

4. Perioperative Cardiac Arrest: Distinct Features and Immediate Management

Perioperative cardiac arrest diverges substantially from conventional algorithms. In >90% of cases, the onset is observed on continuous multi-parameter monitors. Anaesthetists must execute an immediate crisis management protocol: [ SUSPECTED PERIOPERATIVE ARREST ]

  • |
  • +-------------------------+-------------------------+
  • | | |
  • [ Call for Help ] [ Stop Anaesthesia ] [ Stop Surgery ]
  • Arrest team - 100% O2 high flow - Halt stimulation
  • Resuscitation cart - Turn off vaporizers - Desufflate abdomen
  • Defibrillator - Stop TIVA infusions - Release retractors
  • |
  • [ Initiate Resuscitation ]
  • Verify arterial line
  • High-quality CPR
  • Defibrillate if VF/pVT
  • Specific antidote (Lipid/Dantrolene)
  • Critical Perioperative Scenarios

Laparoscopic Peritoneal Insufflation and High Vagal Tone: Rapid peritoneal stretch triggers intense vagal reflexes, causing profound sinus bradycardia or immediate asystole. In addition, excessive intra-abdominal pressure ( > 15 – 20 mmHg >15\text{--}20\text{ mmHg} > 15 – 20 mmHg ) compresses the inferior vena cava, abolishing preload. Management: Demand immediate release of the pneumoperitoneum, administer intravenous atropine ( 0.5 – 1.0 mg 0.5\text{--}1.0\text{ mg} 0.5 – 1.0 mg ) or glycopyrronium, and initiate chest compressions if asystole persists.

High Neuraxial (Spinal/Epidural) Block: Dense sympathectomy extending above T4 blocks cardiac accelerator fibers (T1-T4) and causes venodilation, activating the Bezold-Jarisch reflex (hypotension, severe bradycardia, peripheral pooling). Management: Elevate lower limbs, infuse rapid crystalloid/colloid boluses, and administer adrenaline early ( 10 – 100 μ g 10\text{--}100\text{ }\mu\text{g} 10 – 100 μ g IV titrated; do not rely on weak indirect agents like ephedrine in impending arrest).

Venous Air Embolism (VAE): Prevalent in sitting craniotomies, pelvic surgery, or laparoscopic trocar insertion into large veins. Entrained air forms an "air lock" in the right ventricular outflow tract, causing acute right ventricular failure and cardiovascular collapse. Signs include a sudden plunge in E T CO 2 ET\text{CO}_2 ET CO 2 ​ , hypoxemia, and mill-wheel murmur. Management: Flood the surgical field with saline, place the patient in Durant's position (left lateral decubitus with head down / Trendelenburg) to trap air in the right atrial apex, and aspirate gas through a central venous catheter.

Bone Cement Implantation Syndrome (BCIS): Pressurization of polymethylmethacrylate (PMMA) bone cement during arthroplasty embolizes fat, marrow, and methylmethacrylate monomer into the pulmonary circulation. Characterized by sudden severe hypotension, bronchospasm, elevated pulmonary artery pressure, and PEA arrest. Management: Support right ventricular function with aggressive inotropes, alpha-agonists, and 100% O 2 \text{O}_2 O 2 ​ .

5. Post-Resuscitation Care and Multimodal Neuroprognostication

The post-cardiac arrest syndrome consists of four components: post-cardiac arrest brain injury, post-cardiac arrest myocardial dysfunction, systemic ischemia/reperfusion response, and persistent precipitating pathology.

Hemodynamic and Metabolic Targets (ERC-ESICM Guidelines)

Mean Arterial Pressure (MAP): Avoid hypotension and maintain a MAP of at least about 65 mmHg 65\text{ mmHg} 65 mmHg ; the BOX trial found no benefit from a higher target ( 77 77 77 versus 63 mmHg 63\text{ mmHg} 63 mmHg ), although targets may be individualised in chronic hypertension. Use noradrenaline and dobutamine as needed.

Oxygenation: Titrate F i O 2 Fi\text{O}_2 F i O 2 ​ to maintain an S p O 2 Sp\text{O}_2 Sp O 2 ​ between 94% and 98% ( P a O 2 10 – 13 kPa P_a\text{O}_2\text{ }10\text{--}13\text{ kPa} P a ​ O 2 ​ 10 – 13 kPa / 75 – 100 mmHg 75\text{--}100\text{ mmHg} 75 – 100 mmHg ). Arterial hyperoxia ( P a O 2 > 300 mmHg P_a\text{O}_2 > 300\text{ mmHg} P a ​ O 2 ​ > 300 mmHg ) is strictly avoided because it accelerates free radical production and oxidative neuronal injury.

Ventilation: Maintain normocapnia ( P a CO 2 35 – 45 mmHg P_a\text{CO}_2\text{ }35\text{--}45\text{ mmHg} P a ​ CO 2 ​ 35 – 45 mmHg / 4.5 – 6.0 kPa 4.5\text{--}6.0\text{ kPa} 4.5 – 6.0 kPa ). Hypocapnia induces cerebral vasoconstriction and exacerbates cerebral ischemia; hypercapnia elevates intracranial pressure and induces acidosis.

Temperature Control: The ERC-ESICM 2025 guideline recommends continuous core temperature monitoring and active prevention of fever, keeping temperature at or below 37.5 °C 37.5\text{°C} 37.5 °C for at least 72 hours in patients who remain comatose. Routine induced hypothermia ( 32 – 34 °C 32\text{--}34\text{°C} 32 – 34 °C ) is no longer preferred, because the TTM2 trial showed no benefit over fever control.

Multimodal Neurological Prognostication

Neurological prognostication must never be performed prior to 72 hours post-ROSC , and only after normothermia has been restored and residual effects of sedative, opioid, and neuromuscular blocking drugs have been completely excluded. [ MULTIMODAL NEUROPROGNOSTICATION ]

  • (Evaluated >= 72 hours post-ROSC)
  • |
  • +-------------------+-----------+-----------+-------------------+
  • | | | |
  • [ Clinical Exam ] [ Electrophysiology ] [ Biomarkers ] [ Neuroimaging ]
  • Bilateral loss - Bilateral absence - High serum - Diffuse cortical
  • of pupillary of N20 SSEP wave Neuron-Specific ischemia on CT/MRI
  • and corneal - Malignant EEG Enolase (NSE) - Gray/white matter
  • reflexes (burst suppression) (>60 mcg/L) ratio inversion

Clinical Trap: Relying on a single prognostic indicator introduces an unacceptable risk of falsely predicting a poor outcome. Guideline-mandated practice requires multimodal concordance combining clinical examination, SSEP, continuous EEG, serum NSE quantification, and structural brain neuroimaging.